Overview

Voluven® in Paediatric Patients

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will compare the clinical efficacy and safety of Voluven® and Human Albumin during elective open-heart surgery in pediatric patients.
Phase:
Phase 4
Details
Lead Sponsor:
Fresenius Kabi
Treatments:
Hydroxyethyl Starch Derivatives